#9,945 by institutional money · Stock
FibroBiologics, Inc. (FBLG)
Institutional ownership from Q3 2026 Form 13F filings
$0.83
−1.19% today
Market closed. Prices as of Nov 20, 6:41 AM ET
- 13F holders
- 19 (+2)
- Held by 13F filers, live
- $800K
- Shares held
- 963,934
- Share of stock outstanding
- 10.7%
- Net buying in Q3 2026
- +$564K
- New positions / sold out
- 5 / 3
Largest holders
19 investors| Investor | Shares | Value, live | % of their portfolio | vs Q2 2026 |
|---|---|---|---|---|
| Armistice Capital, LLC | 655,941 | $544K | <0.1% | New |
| Cascade Financial Partners, LLC | 107,828 | $89K | <0.1% | Reduced −1% |
| Vanguard Capital Management LLC | 63,338 | $53K | <0.1% | Added +128% |
| Vanguard Fiduciary Trust Co | 38,638 | $32K | <0.1% | Added +506% |
| Geode Capital Management, LLC | 30,169 | $25K | <0.1% | Reduced −0% |
| IFP Advisors, Inc | 27,000 | $22K | <0.1% | New |
| BlackRock, Inc. | 18,238 | $15K | <0.1% | Unchanged |
| Virtu Financial LLC | 12,163 | $10K | <0.1% | New |
| Tower Research Capital LLC (TRC) | 3,110 | $3K | <0.1% | Reduced −34% |
| Jones Financial Companies Lllp | 2,500 | $2K | <0.1% | New |
| Osaic Holdings, Inc. | 2,300 | $2K | <0.1% | Reduced −4% |
| Royal Bank Of Canada | 1,380 | $1K | <0.1% | Reduced −9% |
| UBS Group AG | 1,072 | $890 | <0.1% | Unchanged |
| Grove Bank & Trust | 100 | $83 | <0.1% | Unchanged |
| BNP Paribas Financial Markets | 64 | $53 | <0.1% | Unchanged |
| BFC Planning, Inc. | 50 | $42 | <0.1% | Unchanged |
| Barclays Plc | 29 | $24 | <0.1% | Reduced −100% |
| Allworth Financial LP | 13 | $11 | <0.1% | Unchanged |
| Citigroup Inc | 1 | $1 | <0.1% | New |